SCHEMBL23218527

SCHEMBL23218527

CCOC(=O)Cc1ccccc1OCc1nn(C(C)C)c2ccc(-c3ccnc(CN)c3)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFD P00746 5/20 0.48
TBXAS1 P24557 1/20 0.39
DPP4 P27487 2/20 0.35
F11 P03951 3/20 0.34
TPSB2 P20231 3/20 0.34
PLG P00747 1/20 0.34
PLAU P00749 1/20 0.34
KLKB1 P03952 1/20 0.34
F7 P08709 1/20 0.34
ICMT O60725 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
AHR P35869 1/20 0.33
SYK P43405 2/20 0.32
PRMT5 O14744 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29852488 1.00 CFD (0.48) CFDTBXAS1DPP4F11TPSB2
SCHEMBL23218786 0.90 CFD (0.44) CFDF11TPSB2PLGPLAU
SCHEMBL29852839 0.90 CFD (0.44) CFDF11TPSB2PLGPLAU
SCHEMBL29852913 0.90 CFD (0.55) CFDTBXAS1DPP4F11TPSB2
SCHEMBL23219207 0.90 CFD (0.55) CFDTBXAS1DPP4F11TPSB2
SCHEMBL23219123 0.88 CFD (0.48) CFDTBXAS1DPP4F11TPSB2
SCHEMBL29853182 0.88 CFD (0.62) CFDTBXAS1DPP4F11TPSB2
SCHEMBL23219243 0.88 CFD (0.62) CFDTBXAS1DPP4F11TPSB2
SCHEMBL29852977 0.88 CFD (0.48) CFDTBXAS1DPP4F11TPSB2
SCHEMBL23219007 0.88 CFD (0.47) CFDTBXAS1DPP4F11TPSB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114502168-A Oral complement factor D inhibitors 拜奥克里斯特制药公司 2022-05-13 CN disclosed
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed